Article Cited by others ORIGINAL ARTICLE
Method development and validation of liquid chromatography-tandem/mass spectrometry for aldosterone in human plasma: Application to drug interaction study of atorvastatin and olmesartan combination
Das Rakesh, Dan Subhasis, Pal Tapan Kumar
Year : 2014| Volume: 5| Issue : 3 | Page no: 108-114 This article has been cited by | 1 |
Developing an ultra-performance liquid chromatography-tandem mass spectrometry for detecting aldosterone in human plasma |
|
| | Wenbin Lin,Zhenrong Yao,Yuzhe Li,Zhihao Liao,Jiahao Xiao,Yonghong Chen,Pinning Feng,Wenjia Gan | | | Journal of Clinical Laboratory Analysis. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | 2 |
Clinical Evaluation of Assays for Plasma Renin Activity and Aldosterone Measurement by Liquid Chromatography–Tandem Mass Spectrometry |
|
| | Stephen M Gibbons,Helen P Field,April Fairhurst,Anne Fleming,Clive Ford,Emma L Williams,Sophie C Barnes,Julian H Barth | | | The Journal of Applied Laboratory Medicine. 2020; | | | [Pubmed] [Google Scholar] [DOI] | | 3 |
Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography–tandem mass spectrometry determinations of plasma aldosterone concentration |
|
| | Stephanie Baron,Laurence Amar,Anne-Laure Faucon,Anne Blanchard,Laurence Baffalie,Catherine Faucard,Simon Travers,Jean-Yves Pagny,Michel Azizi,Pascal Houillier | | | Journal of Hypertension. 2018; 36(7): 1592 | | | [Pubmed] [Google Scholar] [DOI] | | 4 |
Statins: adverse reactions, oxidative stress and metabolic interactions |
|
| | Aimei Liu,Qinghua Wu,Jingchao Guo,Irma Ares,José-Luis Rodríguez,María-Rosa Martínez-Larrañaga,Zonghui Yuan,Arturo Anadón,Xu Wang,María-Aránzazu Martínez | | | Pharmacology & Therapeutics. 2018; | | | [Pubmed] [Google Scholar] [DOI] | | 5 |
Determination of urinary aldosterone using a plasma aldosterone 2D ID LC–MS/MS method |
|
| | Yasin Bekkach,Annemieke C Heijboer,Erik Endert,Mariëtte T Ackermans | | | Bioanalysis. 2016; 8(17): 1765 | | | [Pubmed] [Google Scholar] [DOI] | |
|
|
|
|